title: [Thalidomide in the treatment of cutaneous and systemic sarcoidosis].
abstract: The clinical courses of two patients suffering from generalized or disseminated cutaneous sarcoidosis are described. Both were treated with thalidomide 2 x 100 mg/day, later 100 mg/day. After 8 to 12 months of treatment the skin and systemic lesions had resolved almost completely.
authors.affiliation: Dermatologische Praxen Hamburg und Schwarzenberg.
authors.forename: O
authors.initials: O
authors.lastname: Hoch
authors.forename: S
authors.initials: S
authors.lastname: Müller
authors.forename: G
authors.initials: G
authors.lastname: Büttner
authors.forename: H
authors.initials: H
authors.lastname: Mensing
mesh_terms: D000328:Adult; D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012507:Sarcoidosis / Q000175:diagnosis / Q000188:drug therapy*; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
chemical_list: D003879:Dermatologic Agents; D013792:Thalidomide